FDA.reportPublic FDA data

2 ML pralatrexate 20 MG/ML Injection [Folotyn]

RxCUI
1796425
RxNorm name
2 ML pralatrexate 20 MG/ML Injection [Folotyn]
Display name
2 ML pralatrexate 20 MG/ML Injection [Folotyn]
Full name
2 ML pralatrexate 20 MG/ML Injection [Folotyn]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9f3d9c4d-9386-4451-b712-0fbdc5478d8fFOLOTYN 40 MG in 2 ML Injection [PSN] · 2 ML pralatrexate 20 MG/ML Injection [Folotyn] [SBD] · 2 ML Folotyn 20 MG/ML Injection [SY] · Folotyn 40 MG per 2 ML Injection [SY]49These highlights do not include all the information needed to use FOLOTYN ® safely and effectively. See full prescribing information for FOLOTYN. FOLOTYN (pralatrexate injection), for intravenous use Initial U.S. Approval: 200920240926